Today: 3 July 2026

Khadija Saeed

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Oracle stock price slips as ORCL extends weekly slide; TikTok outage and new AI launches in focus

Oracle stock price slips as ORCL extends weekly slide; TikTok outage and new AI launches in focus

New York, January 30, 2026, 10:55 — Regular session Oracle Corp shares dropped 0.5% to $168.16 on Friday morning, marking a continuation of their week-long decline. This came despite U.S. stock indexes showing only slight losses. The Invesco QQQ, tracking the Nasdaq-100, slipped roughly 0.4%, and the SPDR S&P 500 ETF edged down around 0.2%.
30 January 2026
···
Broadcom stock nudges higher after Wolfe upgrade puts Google TPU ramp back in play

Broadcom stock nudges higher after Wolfe upgrade puts Google TPU ramp back in play

New York, January 30, 2026, 10:43 — Regular session Shares of Broadcom Inc. ticked up roughly 0.3% to $331.71 in mid-morning trading on Friday. Wolfe Research upgraded the stock to Outperform, assigning a $400 price target. Analyst Chris Caso noted in a summary, “we can no longer ignore” Broadcom’s growth and strength in Google’s tensor processing units.
30 January 2026
···
Natural gas price jumps as Freeport LNG returns and storm fallout keeps market edgy

Natural gas price jumps as Freeport LNG returns and storm fallout keeps market edgy

New York, Jan 30, 2026, 10:20 EST — Regular session U.S. natural gas futures pushed higher on Friday, capping a week marked by swings as traders weighed LNG export demand against how quickly supply bounced back after the winter storm. The front-month contract for March delivery gained 16.3 cents, or 4.2%, reaching $4.081 per million British thermal units in early New York trading.
30 January 2026
·
Gold price today: Bullion slips below $5,000 after Trump taps Warsh for Fed chair

Gold price today: Bullion slips below $5,000 after Trump taps Warsh for Fed chair

New York, January 30, 2026, 10:06 AM — Regular session Gold prices plunged on Friday, dipping briefly below $5,000 an ounce after U.S. President Donald Trump announced Kevin Warsh, a former Federal Reserve Governor, as his pick for the next Fed chair. The news boosted the dollar and sparked a wave of profit-taking. By 12:57 GMT, spot gold was down 5.7% at $5,087.99, having touched a low of $4,957.54 earlier. Just the day before, it hit a record $5,594.82.
30 January 2026
··
Sandisk stock jumps as AI storage squeeze drives big forecast and a longer supply deal

Sandisk stock jumps as AI storage squeeze drives big forecast and a longer supply deal

New York, January 30, 2026, 10:06 EST — Regular session Shares of Sandisk jumped roughly 17% to $631.93 on Friday after the flash-storage company raised its quarterly guidance beyond Wall Street’s forecasts. The firm also announced it extended a crucial supply deal with partner Kioxia through 2034. Sandisk projected fiscal third-quarter revenue hitting a midpoint of $4.6 billion, with adjusted earnings per share at $14—far exceeding analysts’ estimates of $2.77 billion in revenue and $4.37 EPS, per LSEG data. CEO David Goeckeler summed it up: “Customers prefer supply over price.”
30 January 2026
···
1 … 343 344 345 346 347 … 877

Stock Market Today

  • AbbVie Jumps 4%, Tops Apogee Buy Price After Earnings Beat
    July 2, 2026, 7:16 PM EDT. AbbVie Inc. finished up 3.99% at $261.07, a new 52-week high. The stock gained nearly $17.8 billion in market cap, putting it well above the $10.9 billion Apogee Therapeutics deal announced June 22. AbbVie closed above targets from RBC Capital, Investing.com and Google Finance. With Q2 earnings set for July 31, the rally puts the spotlight on analyst target hikes. J.P. Morgan and RBC Capital have backed the Apogee buy for its long-term growth, with the company saying the acquisition will add to EPS by 2032. AbbVie outpaced broader markets, which slipped slightly, as investors bet on the drugmaker's deal strategy.
Go toTop